Top Markets
Coin of the day
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
Rangering i aksjer #20489
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Aksjekurs
$20.33
Markedsverdi
$128.73M
Endring (1 dag)
-1.10%
Endring (1 år)
80.41%
Land
PL
Handel Captor Therapeutics Spolka Akcyjna (CTX)

Kategori

Historikk for aksjesplitt for Captor Therapeutics Spolka Akcyjna (CTX)
Aksjen Captor Therapeutics Spolka Akcyjna (symbol: CTX) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 24, 2026.
Én CTX-aksje kjøpt før Aug 24, 2026 tilsvarer i dag 0 CTX-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH